Skip menu navigation Home > Listing of Viewable PTMT Reports > Table of Contents for This Set of Reports


U.S. PATENT AND TRADEMARK OFFICE
Patent Technology Monitoring Team (PTMT)

Patenting In Technology Classes,
Breakout By Organization

Count of 2008 - 2012 Utility Patent Grants,
By Calendar Year of Grant
With Patent Counts Based on Primary Patent Classification

- Explanation of Data -

Rank Ordered Listing of Organizations Receiving 5 or More Utility Patents During the Period
Having Primary Classification In

Class 530, Chemistry: Natural Resins or Derivatives; Peptides or Proteins; Lignins or Reaction Products Thereof

( technology class is determined by the primary classification assigned to the patent- see 'Explanation of Data' )
( patent ownership is determined by the first-named assignee listed on a patent )

The following table displays first-named assignees and counts of their associated patents, as distributed by the year of patent grant.
First-Named Assignee 2008 2009 2010 2011 2012 Total
GENENTECH, INC. 167 34 36 18 11 266
~INDIVIDUALLY OWNED PATENT 29 21 32 27 27 136
AMGEN, INC. 10 6 23 16 12 67
UNIVERSITY OF CALIFORNIA, THE REGENTS OF 18 13 14 6 12 63
ZYMOGENETICS, INC. 4 33 11 6 7 61
UNITED STATES OF AMERICA, DEPARTMENT OF HEALTH & HUMAN SERVICES 16 11 8 12 2 49
SCHERING CORP. 7 11 7 15 6 46
HUMAN GENOME SCIENCES, INC. 15 7 4 6 5 37
BRISTOL-MYERS SQUIBB COMPANY 7 6 10 5 4 32
IMMUNEX CORPORATION 9 8 6 6 1 30
LUDWIG INSTITUTE FOR CANCER RESEARCH 5 6 7 7 2 27
PIONEER HI-BRED INTERNATIONAL, INC. 4 12 5 5 1 27
ABBOTT LABORATORIES 1 13 2 5 5 26
AGENSYS, INC. 3 3 6 11 3 26
E. I. DU PONT DE NEMOURS AND COMPANY 1 6 7 10 2 26
XENCOR, INC. 5 3 4 4 10 26
UNIVERSITY OF TEXAS 6 4 6 5 4 25
ALLERGAN, INC. 3 3 9 5 3 23
BIOGEN IDEC MA INC. 6 3 3 9 2 23
CHUGAI SEIYAKU KABUSHIKI KAISHA 0 3 6 9 4 22
MILLENNIUM PHARMACEUTICALS, INC. 12 1 5 2 1 21
NOVARTIS AG (FORMERLY SANDOZ LTD.) 2 2 3 5 9 21
ELI LILLY AND COMPANY 3 4 3 4 5 19
SCRIPPS RESEARCH INSTITUTE 4 3 4 4 4 19
BAXTER INTERNATIONAL INC. 0 0 1 14 3 18
MEDAREX, INC. 2 2 3 4 7 18
MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG 8 4 1 3 2 18
STANFORD UNIVERSITY 2 1 5 5 5 18
WISCONSIN ALUMNI RESEARCH FOUNDATION 3 3 6 3 3 18
HOFFMANN-LA ROCHE INC. 3 4 0 4 6 17
JOHNS HOPKINS UNIVERSITY 6 3 2 3 3 17
NOVO NORDISK A/S 4 2 2 4 5 17
WYETH 2 4 4 5 2 17
AMBRX, INC. 2 1 1 5 7 16
KYOWA HAKKO KIRIN CO., LTD. 0 1 2 7 5 15
GENETICS INSTITUTE, INC. 4 5 3 2 0 14
IMMUNOMEDICS INC. 1 5 1 5 2 14
SENOMYX, INC. 0 0 6 6 2 14
UNIVERSITY OF ILLINOIS 2 4 3 3 2 14
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS 2 4 1 4 2 13
DANA-FARBER CANCER INSTITUTE, INC. 0 2 7 2 2 13
MACROGENICS, INC. 3 1 4 2 3 13
YEDA RESEARCH AND DEVELOPMENT CO., LTD. 2 3 3 3 2 13
CRUCELL HOLLAND, B.V. 0 2 4 1 5 12
IMMATICS BIOTECHNOLOGIES GMBH 1 1 2 4 4 12
REGENERON PHARMACEUTICALS, INC. 3 5 1 2 1 12
THERAVANCE, INC. 5 1 3 2 1 12
YALE UNIVERSITY 2 3 2 3 2 12
ARES-TRADING S.A. 1 3 4 1 2 11
ARIUS RESEARCH, INC. 11 0 0 0 0 11
CENTOCOR, INC. 2 3 2 2 2 11
COLUMBIA UNIVERSITY 4 2 2 2 1 11
GENERAL HOSPITAL CORPORATION 4 2 2 2 1 11
INSTITUT PASTEUR 3 1 5 0 2 11
JAPAN SCIENCE AND TECHNOLOGY AGENCY 1 3 2 5 0 11
ROCHE DIAGNOSTICS OPERATIONS, INC. 2 3 4 2 0 11
UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION 2 3 4 0 2 11
UNIVERSITY OF MINNESOTA, THE REGENTS OF 2 2 3 2 2 11
AMYLIN PHARMACEUTICALS, INC. 0 3 4 2 1 10
BOLDER BIOTECHNOLOGY, INC. 4 1 3 0 2 10
MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2 1 3 3 1 10
NOVARTIS VACCINES AND DIAGNOSTICS, INC. 1 3 2 3 1 10
TUFTS UNIVERSITY 0 3 3 3 1 10
UCB PHARMA S.A. 3 2 1 3 1 10
UNIVERSITY OF MASSACHUSETTS 3 0 3 2 2 10
UNIVERSITY OF PENNSYLVANIA 0 2 3 4 1 10
AMGEN FREMONT INC. 1 3 4 0 1 9
BIO-RAD LABORATORIES, INC. 0 1 2 3 3 9
BURNHAM INSTITUTE FOR MEDICAL RESEARCH 1 5 0 2 1 9
DOW AGROSCIENCES LLC 0 3 2 2 2 9
FLORIDA STATE UNIVERSITY 1 1 3 0 4 9
GE HEALTHCARE BIO-SCIENCES AB 3 0 3 0 3 9
GREEN PEPTIDE CO., LTD. 4 2 1 1 1 9
HARVARD COLLEGE, PRESIDENT AND FELLOWS 5 1 2 0 1 9
IMMUNOGEN INC. 0 2 1 3 3 9
JURIDICAL FOUNDATION, THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE 1 3 1 1 3 9
LOUISIANA TECH UNIVERSITY FOUNDATION, INC. 3 4 1 1 0 9
MEDIMMUNE, LLC 1 0 4 2 2 9
NEKTAR THERAPEUTICS 0 0 2 2 5 9
RAMOT AT TEL AVIV UNIVERSITY LTD. 0 1 1 2 5 9
ROCKEFELLER UNIVERSITY 2 4 1 1 1 9
SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 0 0 1 5 3 9
TAKEDA PHARMACEUTICAL COMPANY LIMITED 2 3 4 0 0 9
ALEXION PHARMACEUTICALS, INC. 5 2 1 0 0 8
CEM CORPORATION 1 3 0 2 2 8
CHILDREN'S MEDICAL CENTER CORPORATION 4 1 2 0 1 8
COMPUGEN LTD. 2 1 3 2 0 8
CORIXA CORPORATION 2 1 1 3 1 8
CORNELL RESEARCH FOUNDATION INC. 3 1 0 3 1 8
DYAX CORP. 1 1 1 3 2 8
INVENTION SCIENCE FUND I, LLC 0 0 2 6 0 8
ISIS INNOVATION LIMITED 1 0 3 2 2 8
JANSSEN PHARMACEUTICA N.V. 1 2 1 2 2 8
NEW YORK UNIVERSITY 2 1 3 1 1 8
PALATIN TECHNOLOGIES, INC. 4 1 1 1 1 8
TEXAS A AND M UNIVERSITY 0 4 4 0 0 8
UNITED STATES OF AMERICA, DEPARTMENT OF AGRICULTURE 1 0 1 4 2 8
UNIVERSITY OF ARKANSAS 0 3 1 1 3 8
UNIVERSITY OF MARYLAND 2 1 4 0 1 8
ACADEMIA SINICA 1 1 2 0 3 7
BRIGHAM AND WOMEN'S HOSPITAL, INC. 1 0 2 3 1 7
CELL SIGNALING TECHNOLOGY, INC. 0 0 1 6 0 7
DANISCO US INC 0 0 2 3 2 7
DUKE UNIVERSITY 0 4 1 2 0 7
FUJIFILM MANUFACTURING EUROPE B.V. 0 2 0 2 3 7
GLAXO GROUP LIMITED 0 1 2 1 3 7
IDEXX LABORATORIES, INC. 1 2 1 0 3 7
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE 1 3 1 0 2 7
INTERNATIONAL INSTITUTE OF CANCER IMMUNOLOGY, INC. 2 2 2 1 0 7
MERCK + CO., INC. 5 2 0 0 0 7
ONCOTHERAPY SCIENCE, INCORPORATED 1 0 3 3 0 7
OTSUKA PHARMACEUTICAL CO., LTD. 0 2 3 1 1 7
UNIVERSITY OF ROCHESTER 1 1 2 1 2 7
AFFINERGY, INC. 0 0 4 2 0 6
BIOCON LIMITED 1 1 0 4 0 6
DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS 0 2 1 1 2 6
DIADEXUS, INC. 0 3 2 0 1 6
HESKA CORPORATION 3 2 0 1 0 6
ICAGEN, INC. 3 2 0 1 0 6
IMMUNOCORE LIMITED 0 1 0 2 3 6
INTREXON CORPORATION 0 0 2 2 2 6
MERCK SHARP & DOHME CORP. 0 0 1 2 3 6
MOCHIDA PHARMACEUTICAL CO., LTD. 0 3 0 1 2 6
NATIONAL RESEARCH COUNCIL OF CANADA 0 2 1 3 0 6
NOVO NORDISK HEALTH CARE AG 1 0 2 2 1 6
ONO PHARMACEUTICAL COMPANY, LIMITED 1 1 1 2 1 6
SALADAX BIOMEDICAL INC. 1 0 1 2 2 6
SANOFI PASTEUR LIMITED 1 4 1 0 0 6
SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH 0 1 1 3 1 6
SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) 2 4 0 0 0 6
UNIVERSITY OF DELAWARE 1 1 1 3 0 6
UNIVERSITY OF SOUTHERN CALIFORNIA 3 0 1 2 0 6
ALBANY MEDICAL COLLEGE 0 1 1 3 0 5
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY 0 1 3 1 0 5
ATHENIX CORPORATION 0 1 1 0 3 5
BAYER HEALTHCARE, LLC 0 1 3 0 1 5
CENTOCOR ORTHO BIOTECH INC. 0 1 0 1 3 5
DSM IP ASSETS B.V. 0 2 1 1 1 5
FIVE PRIME THERAPEUTICS, INC. 0 0 2 2 1 5
FUJI OIL CO., LTD. 0 2 1 0 2 5
FUSO PHARMACEUTICAL INDUSTRIES, LTD. 0 3 0 2 0 5
GENENCOR INTERNATIONAL, INC. 2 3 0 0 0 5
MASSACHUSETTS INSTITUTE OF TECHNOLOGY 0 1 0 3 1 5
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN E.V 3 2 0 0 0 5
MAXYGEN, INC. 0 5 0 0 0 5
MERCK SERONO SA 0 1 3 1 0 5
MORPHOTEK, INC. 1 1 2 0 1 5
NOVIMMUNE SA 0 0 3 0 2 5
NOVOZYMES A/S 2 0 0 1 2 5
ONCOMED PHARMACEUTICALS, INC. 0 0 2 1 2 5
OREGON HEALTH SCIENCES UNIVERSITY 0 1 1 2 1 5
ORTHO-MCNEIL PHARMACEUTICAL, INC. 1 0 1 1 2 5
PIERIS AG 0 1 2 1 1 5
RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK 0 1 4 0 0 5
RIKEN 0 1 1 2 1 5
ROCHE PALO ALTO LLC 1 1 0 2 1 5
SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH 0 2 2 0 1 5
UNITED STATES OF AMERICA, NAVY 1 1 0 1 2 5
UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED 0 2 1 2 0 5
UNIVERSITY OF NEBRASKA, THE BOARD OF REGENTS OF 1 1 1 1 1 5
UNIVERSITY OF QUEENSLAND 1 1 1 1 1 5
UNIVERSITY OF SOUTH FLORIDA 2 0 3 0 0 5
VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE (VIB) VZW 0 1 1 3 0 5


PTMT Contacts

Questions regarding these reports should be directed to:

U.S. Patent and Trademark Office
Electronic Information Products Division - PTMT
P.O Box 1450
Alexandria VA 22313-1450

tel: (571) 272-5600
fax: (571) 273-0110
email: oeip@uspto.gov

address of PTMT pages at the USPTO Web Site: http://www.uspto.gov/web/offices/ac/ido/oeip/taf/tafp.html
selected PTMT files available for download at : http://www.uspto.gov/web/offices/ac/ido/oeip/taf/data/


Top

Skip menu navigation Home > Listing of Viewable PTMT Reports > Table of Contents for This Set of Reports